Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 6 | 6 | 7 | 6 |
Avg. Estimate | -0.29 | -0.08 | -1.04 | -0.78 |
Low estimate | -0.42 | -0.52 | -2.34 | -2.35 |
High estimate | -0.13 | 1.38 | -0.24 | 0.88 |
Year ago EPS | -0.36 | -0.76 | -1.72 | -1.04 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 6 | 6 | 7 | 6 |
Avg. Estimate | 17.43M | 33.94M | 95.04M | 122.26M |
Low estimate | 5.2M | 6.79M | 25M | 30M |
High estimate | 34.51M | 135.2M | 165M | 272.15M |
Year ago sales | 35.58M | 12.36M | 76.01M | 95.04M |
Sales growth (year/est) | -51.00% | 174.60% | 25.00% | 28.60% |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|---|---|---|---|
Est. EPS | -0.54 | -0.47 | -0.47 | -0.43 |
Actual EPS | -0.36 | -0.76 | -0.41 | -0.2 |
Difference | 0.18 | -0.29 | 0.06 | 0.23 |
Surprise % | 33.30% | -61.70% | 12.80% | 53.50% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | -0.29 | -0.08 | -1.04 | -0.78 |
7 days ago | -0.29 | -0.08 | -1.04 | -0.78 |
30 days ago | -0.29 | -0.08 | -1.04 | -0.78 |
60 days ago | -0.49 | -0.07 | -1.22 | -1.12 |
90 days ago | -0.39 | -0.4 | -1.2 | -1.08 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | 1 | N/A | N/A |
Up last 30 days | N/A | 1 | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | 1 |
Growth estimates | ZYME | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 19.40% | N/A | N/A | N/A |
Next qtr. | 89.50% | N/A | N/A | N/A |
Current year | 39.50% | N/A | N/A | N/A |
Next year | 25.00% | N/A | N/A | N/A |
Next 5 years (per annum) | 11.00% | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |